Advertisement

Topics

Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq

07:56 EDT 10 Jul 2017 | Labiotech.eu

Zealand Pharma, known for its partnership with Sanofi to boost the insulin blockbuster Lantus, is aiming high in an IPO on the US Nasdaq. Zealand Pharma has announced it has already filed for an IPO at the Nasdaq Global Select Market, ...

This awesome article Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq

NEXT ARTICLE

More From BioPortfolio on "Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...